Literature DB >> 23604867

Growth hormone and aging.

A Bartke1, H Brown-Borg, B Kinney, J Mattison, C Wright, S Hauck, K Coschigano, J Kopchick.   

Abstract

The potential usefulness of growth hormone (GH) as an anti-aging therapy is of considerable current interest. Secretion of GH normally declines during aging and administration of GH can reverse age-related changes in body composition. However, mutant dwarf mice with congenital GH deficiency and GH resistant GH-R-KO mice live much longer than their normal siblings, while a pathological elevation of GH levels reduces life expectancy in both mice and men. We propose that the actions of GH on growth, development, and adult body size may serve as important determinants of aging and life span, while the age-related decline in GH levels contributes to some of the symptoms of aging.

Entities:  

Year:  2000        PMID: 23604867      PMCID: PMC3455269          DOI: 10.1007/s11357-000-0021-x

Source DB:  PubMed          Journal:  J Am Aging Assoc        ISSN: 2152-4041


  48 in total

Review 1.  Neuroendocrine control of growth hormone secretion.

Authors:  G S Tannenbaum
Journal:  Acta Paediatr Scand Suppl       Date:  1991

Review 2.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Authors:  A Giustina; J D Veldhuis
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

3.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

Authors:  Y Zhou; B C Xu; H G Maheshwari; L He; M Reed; M Lozykowski; S Okada; L Cataldo; K Coschigamo; T E Wagner; G Baumann; J J Kopchick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  Human growth hormone.

Authors:  J S Strobl; M J Thomas
Journal:  Pharmacol Rev       Date:  1994-03       Impact factor: 25.468

5.  Increased glial fibrillary acidic protein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene.

Authors:  D B Miller; A Bartke; J P O'Callaghan
Journal:  Exp Gerontol       Date:  1995 May-Aug       Impact factor: 4.032

Review 6.  The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing.

Authors:  A P D'Costa; R L Ingram; J E Lenham; W E Sonntag
Journal:  J Reprod Fertil Suppl       Date:  1993

Review 7.  Does growth hormone prevent or accelerate aging?

Authors:  A Bartke; H M Brown-Borg; A M Bode; J Carlson; W S Hunter; R T Bronson
Journal:  Exp Gerontol       Date:  1998 Nov-Dec       Impact factor: 4.032

8.  Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency.

Authors:  H B Baum; L Katznelson; J C Sherman; B M Biller; D L Hayden; D A Schoenfeld; K E Cannistraro; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

9.  Crystals of human growth hormone-receptor complexes. Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent receptor dimerization.

Authors:  M Ultsch; A M de Vos
Journal:  J Mol Biol       Date:  1993-06-20       Impact factor: 5.469

10.  Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse.

Authors:  K E Borg; H M Brown-Borg; A Bartke
Journal:  Proc Soc Exp Biol Med       Date:  1995-11
View more
  7 in total

Review 1.  Hormonal regulation of longevity in mammals.

Authors:  Holly M Brown-Borg
Journal:  Ageing Res Rev       Date:  2007-02-20       Impact factor: 10.895

2.  IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan.

Authors:  Nicole M Ashpole; Sreemathi Logan; Andriy Yabluchanskiy; Matthew C Mitschelen; Han Yan; Julie A Farley; Erik L Hodges; Zoltan Ungvari; Anna Csiszar; Sixia Chen; Constantin Georgescu; Gene B Hubbard; Yuji Ikeno; William E Sonntag
Journal:  Geroscience       Date:  2017-04-13       Impact factor: 7.713

3.  Skeletal muscle growth defect in human growth hormone transgenic rat is accompanied by phenotypic changes in progenitor cells.

Authors:  Shingo Shibata; Chiori Ueno; Tsuyoshi Ito; Keitaro Yamanouchi; Takashi Matsuwaki; Masugi Nishihara
Journal:  Age (Dordr)       Date:  2010-01-23

Review 4.  Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.

Authors:  Manuchair Ebadi; Holly Brown-Borg; Hesham El Refaey; Brij B Singh; Scott Garrett; Shaik Shavali; Sushil K Sharma
Journal:  Brain Res Mol Brain Res       Date:  2005-03-24

5.  Metabolic adaptations to short-term every-other-day feeding in long-living Ames dwarf mice.

Authors:  Holly M Brown-Borg; Sharlene Rakoczy
Journal:  Exp Gerontol       Date:  2013-07-04       Impact factor: 4.032

Review 6.  Hormonal control of aging in rodents: the somatotropic axis.

Authors:  Holly M Brown-Borg
Journal:  Mol Cell Endocrinol       Date:  2008-07-11       Impact factor: 4.102

7.  Disparate Central and Peripheral Effects of Circulating IGF-1 Deficiency on Tissue Mitochondrial Function.

Authors:  Gavin Pharaoh; Daniel Owen; Alexander Yeganeh; Pavithra Premkumar; Julie Farley; Shylesh Bhaskaran; Nicole Ashpole; Michael Kinter; Holly Van Remmen; Sreemathi Logan
Journal:  Mol Neurobiol       Date:  2019-11-15       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.